(Q46573379)

English

Sensitivity to further endocrine therapy is retained following progression on first-line fulvestrant.

scientific article published in July 2005

Statements

Sensitivity to further endocrine therapy is retained following progression on first-line fulvestrant (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit